Hunting for next big eye disease drug, Regeneron gets deeper into gene therapies with ViGeneron pact

Regeneron is dipping its toe deeper into the gene therapy waters, teaming up with ViGeneron to work on a retinal disease prospect based on engineered recombinant adeno-associated virus vectors (vgAAVs).